/LUCY
Innovative Eyewear, Inc.
LUCY • NASDAQLUCY • NASDAQ • Healthcare
$1.07-4.46%-0.05
$1.07-4.46%(-0.05)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
70Bullish
Risk
0High Risk
Momentum
0Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
13.1%▲23.5pp
Revenue after COGS
Operating
-484.2%▲110.6pp
After operating expenses
Net
-474.6%▲103.6pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-0.9
Price vs earnings
EV/EBITDA
-0.6
Enterprise value
FCF Yield
-95.2%
Cash generation
Earnings Yield
-105.5%
Inverse of P/E
Capital Efficiency
-85
GoAI Quality ScorePoor
ROEReturn on Equity
-85.4%Weak
ROAReturn on Assets
-78.9%Weak
ROICReturn on Invested Capital
-87.1%Weak
Financial Health
Current RatioHealthy
12.52
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
0.35x
Debt repayment capacity (<3x)
Income QualityFair
0.87
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.64M | $1.15M | $659.79K | $690.67K | $57.00K |
| Gross Profit | $215.19K | -$119.33K | -$56.29K | $148.25K | -$17.27K |
| Gross Margin | 13.1% | -10.4% | -8.5% | 21.5% | -30.3% |
| Operating Income | -$7.92M | -$6.86M | -$5.58M | -$3.21M | -$653.01K |
| Net Income | -$7.77M | -$6.66M | -$5.68M | -$3.24M | -$768.18K |
| Net Margin | -474.6% | -578.2% | -861.2% | -469.8% | -1347.8% |
| EPS | -$5.19 | -$12.67 | -$17.41 | -$12.37 | -$5.19 |
Rating Distribution
Strong Buy
0
0%
Buy
1
100%
Hold
0
0%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Maxim Group● Maintain
Buy
2024-03-26Earnings History & Surprises
BEAT RATE
56%
Last 9 quarters
AVG SURPRISE
-640.8%
EPS vs Estimate
BEATS / MISSES
5/4
Last 9 quarters
LATEST EPS
$-0.38
Q4 '25
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q4 '25
+22.4%
$-0.38 vs $-0.49
Q3 '25
+14.3%
$-0.66 vs $-0.77
Q2 '25
+1.4%
$-0.72 vs $-0.73
Q1 '25
+66.4%
$-0.41 vs $-1.22
Q4 '24
+38.1%
$-0.99 vs $-1.60
Q3 '24
-16.9%
$-1.87 vs $-1.60
Q2 '24
-1664.7%
$-3.00 vs $-0.17
Q1 '24
-2614.3%
$-3.80 vs $-0.14
Q4 '23
-1614.3%
$-2.40 vs $-0.14
Q3 '23
No data
Q2 '23
No data
Q1 '23
No data
No investor questions available.
Latest News
No news available